Cite
Gozzi F, Aldigeri R, Mastrofilippo V, et al. Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy. Ocul Immunol Inflamm. 2021;1-9doi: 10.1080/09273948.2021.1962916.
Gozzi, F., Aldigeri, R., Mastrofilippo, V., De Simone, L., Bolletta, E., Marzano, J., Iannetta, D., Coassin, M., Ilariucci, F., Ferrari, A., Luminari, S., Merli, F., Croci, S., Zerbini, A., Farnetti, E., Nicoli, D., Valli, R., Tamagnini, I., Cavazza, A., Salvarani, C., Fontana, L., & Cimino, L. (2021). Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy. Ocular immunology and inflammation, 1-9. https://doi.org/10.1080/09273948.2021.1962916
Gozzi, Fabrizio, et al. "Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy." Ocular immunology and inflammation vol. (2021): 1-9. doi: https://doi.org/10.1080/09273948.2021.1962916
Gozzi F, Aldigeri R, Mastrofilippo V, De Simone L, Bolletta E, Marzano J, Iannetta D, Coassin M, Ilariucci F, Ferrari A, Luminari S, Merli F, Croci S, Zerbini A, Farnetti E, Nicoli D, Valli R, Tamagnini I, Cavazza A, Salvarani C, Fontana L, Cimino L. Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy. Ocul Immunol Inflamm. 2021 Aug 11;1-9. doi: 10.1080/09273948.2021.1962916. Epub 2021 Aug 11. PMID: 34379571.
Copy
Download .nbib